Navigation Links
Prostate Cancer in Obese Men

Two new studies show obese men with prostate cancer are at a higher risk of developing more aggressive tumors and of experiencing cancer recurrence than men of normal weight.//

The first study conducted by researchers at the Naval Medical Center in San Diego sampled nearly 3,200 prostate cancer patients. In this group, 19 percent of the patients were considered obese -- defined as having a body mass index higher than 30.

Researchers found a correlation between obesity and a higher Gleason score, the value used to classify the aggressiveness of prostate tumors. They also found obese men tended to have a higher cancer recurrence rate.

The second study was conducted by researchers at Johns Hopkins University School of Medicine on nearly 1,100 prostate cancer patients, 22 percent of who were obese. In this study, obesity was defined as a body mass index higher than 35. As in the first study, researchers concluded that obese men also were more like to have a higher Gleason score. Another similar conclusion was that in both studies black men were more likely to be obese.

Stephen J. Freedland, M.D., co-author of the study, says, "We suspect that worse outcomes among African-American men with prostate cancer are related to obesity rather than race."

Researchers for both studies suggest that proteins and hormones stored in body fat -- such as leptin and insulin-like growth factor 1 -- may encourage prostate tumor growth in obese men. Also, obese men usually have lower testosterone levels and higher estrogen levels, which may promote cancer growth. In addition, diets high in fat may promote tumor growth.

Medical peers agree with the conclusions of the studies and encourage further investigation. Alfred I. Neugut, M.D., Ph. D., of Columbia University, says, "The number of prostate cancer survivors is steadily increasing, and it will be important to investigate if weight loss and other lifestyle changes can impr ove prognosis in those already diagnosed with prostate cancer."


'"/>




Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
3. New Prostate Cancer Vaccine Shows Promise
4. Hormone Therapy applicable for Prostate Cancer
5. Prostate cancer and Vitamins
6. Response to chemotherapy could be measured by Prostate-Specific Antigen Doubling Time
7. Early Detection Of Prostate Cancer
8. Awareness increase Prostate cancer detection
9. Better Prostate Cancer Test
10. Stopping Prostate Cancer from Spreading
11. Drug might prevent Prostate Cancer Spread
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/19/2017)... ... ... Next week after January 20th, the fear for many is that the humane ... of over 30 million. Many interviews with Dr. Carol Francis at the Los Angeles ... suppose to prioritize. Interviews provided below. , Among those present was Senator ...
(Date:1/19/2017)... (PRWEB) , ... January 19, 2017 , ... With the cold weather here, many people ... Snow blowers are efficient when clearing large amounts of snow, but they can be dangerous ... the U.S. Consumer Product Safety Commission for the proper use of snow blowers:, ...
(Date:1/19/2017)... ... 19, 2017 , ... LabRoots , the leading provider ... world, announces the launch of its newly redesigned website. The sleek new design ... and trending news, vital information on upcoming virtual events and webinars, all while ...
(Date:1/19/2017)... ... January 19, 2017 , ... Remote Medical Technologies ... impressive transportable capabilities with their iMedHD2™ Portable Teleultrasound System. Compatible ... technology that delivers HD, dynamic, streaming ultrasound images and video to one or ...
(Date:1/19/2017)... ... 19, 2017 , ... WholeHealth is announcing their participation in ... Andrew Petersen and Trish Henrie-Barrus will be present Saturday and Sunday in the ... , “We know it’s easy to get carried away when you’re having ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 19, 2017 Incretin Mimetics/GLP-1 Agonists, SNDRIs, Lipase ... The global anti-obesity drugs market is expected to ... the forecast period and CAGR of 38.7% in the second half ... a CAGR of 32.8% from 2016 to 2027. The market is ... $24,063 million in 2027. ...
(Date:1/19/2017)... 2017  Sensus Healthcare, Inc. (NASDAQ: ... the treatment of non-melanoma skin cancers and other ... therapy, today announced that it will report its ... on Thursday, February 2, 2017 after the market close. ... call with the investment community on Thursday, February 2, ...
(Date:1/19/2017)... LONDON , January 19, 2017 ... New Therapeutic Option to Address Motor Symptoms and ... ...      (Logo: http://photos.prnewswire.com/prnh/20151014/276718LOGO) ... Fabrizio Stocchi , European Neurological Review,2016;11(Suppl. 2): 2-15, ...
Breaking Medicine Technology: